Barnidipine Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Barnidipine Used in the treatment of hypertension, barnidipine displays high affinity for the calcium channels of the smooth muscle cells in the vascular wall 8 and selectivity against cardiovascular L-type calcium channels 1. Barnidipine contains two chiral centres thus can have four possible enantiomers.Barnidipine Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Barnidipine Nitroso CAS NO:NA chemically represented as 3-((S)-1-Benzylpyrrolidin-3-yl) 5-methyl (S)-2,6-dimethyl-4-(3-nitrophenyl)-1-nitroso-1,4-dihydropyridine-3,5-dicarboxylate.Synchemia is the leading manufacturing and exporter of Barnidipine Nitroso .We supply Barnidipine Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142291 |
| CAS No | NA |
| Mol.F. | C9H11N3O4 |
| Mol.Wt. | 225.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142292 |
| CAS No | NA |
| Mol.F. | C16H13ClN4O2 |
| Mol.Wt. | 328.76 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142293 |
| CAS No | NA |
| Mol.F. | C18H15ClN4O2 |
| Mol.Wt. | 354.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142294 |
| CAS No | NA |
| Mol.F. | C16H13ClN4O2 |
| Mol.Wt. | 328.76 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142295 |
| CAS No | NA |
| Mol.F. | C20H21ClN4O3 |
| Mol.Wt. | 400.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142296 |
| CAS No | NA |
| Mol.F. | C18H19ClN4O2 |
| Mol.Wt. | 358.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142297 |
| CAS No | NA |
| Mol.F. | C17H15ClN4O3 |
| Mol.Wt. | 358.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142298 |
| CAS No | NA |
| Mol.F. | C17H15ClN4O3 |
| Mol.Wt. | 358.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142299 |
| CAS No | NA |
| Mol.F. | C17H17ClN4O3 |
| Mol.Wt. | 360.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142300 |
| CAS No | NA |
| Mol.F. | C17H17ClN4O3 |
| Mol.Wt. | 360.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142301 |
| CAS No | NA |
| Mol.F. | C13H7ClN2O3 |
| Mol.Wt. | 274.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142302 |
| CAS No | NA |
| Mol.F. | C16H18N4O6S |
| Mol.Wt. | 394.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142303 |
| CAS No | NA |
| Mol.F. | C16H20N4O7S |
| Mol.Wt. | 412.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142304 |
| CAS No | NA |
| Mol.F. | C15H20N4O5S |
| Mol.Wt. | 368.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142305 |
| CAS No | NA |
| Mol.F. | C48H55N11O17S3 |
| Mol.Wt. | 1154.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142306 |
| CAS No | NA |
| Mol.F. | C32H38N8O13S2 |
| Mol.Wt. | 806.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |